|
|
 Cardiovascular Information - December 1, 2008
| New research released on Tuesday finds that in 2005, Attention Deficit Hyperactivity Disorder (ADHD) drug usage spiked sharply among younger adults, while children's overall usage grew at a much slower rate. Currently the Food and Drug Administration (FDA) is reviewing cardiovascular and psychiatric side effects of medications for ADHD. According to the analysis by Medco Health Solutions, Inc. the number of younger adults aged 20 to 44 prescribed ADHD medications skyrocketed more than 139 percent from 2000 to 2005, outpacing increases in children 19 and younger by 82 percent | | Boston, Massachusetts (AHN)-A new study in the New England Journal of Medicine offers intriguing insight into the possibility of postponing hypertension among the 59 million Americans whose blood pressure is slightly high | | When diet and exercise regimens fail, surgery has become an increasingly popular solution, as rates of obesity in America continue to rapidly rise. According to News-Medical.Net, bariatric surgery is now an approved therapeutic intervention for class II-III obesity, and may correlate to improved risk for heart disease | | Researchers find a new cholesterol-lowering statin drug that reverses the build-up of plaque in coronary arteries, which, according to reports, can lead to a heart attack or stroke. According to Reuters, a study of more than 500 patients found that after two years of treatment with a high dose of AstraZeneca Plc's Crestor, plaque volumes decrease | | According to a study conducted by Ohio University, Nebivolol, a drug for treatment of high blood pressure currently available in Europe, may restore damaged cardiovascular functions in African Americans. Researchers identified the drug currently under review by the U.S. Food and Drug Administration, acts on the level of oxidants lining the cardiovascular system and can restore levels of nitric oxide and reduce oxidative stress | |
|
|
